Shukra Pharma.

Shukra_Pharma.26 Apr 2024

Pharmaceuticals

₹

+1.80 (+1.97%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Shukra Pharma.

Shukra Pharma.

Pharmaceuticals

Shukra_Pharma.26 Apr 2024

₹

+1.80 (+1.97%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
29-May-2023	D	Board Meeting Outcome for Considered And Approved The Standalone Financial Result For The Quarter And Financial Year Ended March 31, 2023 And Recommended Final Dividend Recommendation of final dividend of 5% (Rs. 0.50 per equity share of Rs. 10 each face value) for the Financial Year 2022-23, subject to the approval of shareholders in the ensuing Annual General Meeting.	15-Sep-2023
28-May-2022	D	The Board of Directors of the Company in their meeting held to-day have approved and taken on record financial results, on standalone for quarter/year ended on 31st March, 2022 audited by the Company''s Statutory Auditors, M/s Maak & Associates and reviewed by Company'' Audit Committee in their meeting also held earlier today. The Board of Directors have also recommended the final dividend of 5% (Rs. 0.50 per equity share of Rs. 10 each face value) for the financial year 2021-22, subject to the approval of the Shareholders in the ensuing Annual General Meeting. Intimation Of Record Date For The Purpose Of Dividend For The Financial Year 2021-22. (As Per BSE Announcement Dated on 10.09.2022)	22-Sep-2022
16-Jul-2019	D	With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on 15th July, 2019 at 01:00 p.m. and concluded on 02:00 p.m. Board of Directors has recommended a dividend @ Rs. 0.50/- per Equity Shares, i.e. 5 % on Equity Shares subject to approval of members at the ensuing Annual General Meeting.	19-Sep-2019
29-May-2018	D	Shukra Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2018, inter alia, have recommended a dividend of Rs. 0.5/- per Equity share, i.e. @ 5% on Equity shares subject to approval of members at the ensuing Annual General Meeting.	31-Aug-2018
01-Jun-2017	D	Shukra Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2017, inter alia, have recommended a dividend @ Rs. 0.5/ - per Equity Shares, i.e.5% on Equity Shares subject to approval of members at the ensuing Annual General Meeting.	01-Sep-2017
08-Apr-2024	B	3:1 Bonus Issues of Equity Shares Trading Members of the Exchange are hereby informed that, SHUKRA PHARMACEUTICALS LIMITED has fixed Record Date for the purpose of Bonus Issue of Equity Shares of the Company. The transactions in the Equity Shares of the Company would be on an Ex-Bonus basis with effect from the under mentioned date :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE SHUKRA PHARMACEUTICALS LIMITED (524632) RECORD DATE 20/04/2024 PURPOSE Issue of 03 (Three) Bonus Equity Shares of Rs.10/- each for every 01 (One) existing Equity Share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 19/04/2024 DR- 614/2024-2025 (As Per BSE Notice Dated on 09.04.2024)	20-Apr-2024	3:1
18-Jan-2023	R	6:1 Rights Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Shukra Pharmaceuticals Limited has fixed Record date for the purpose of Rights Issue of Equity Shares. The transactions in the Equity Shares of the Company should be done on Ex-Rights basis with effect from the under mentioned date :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Shukra Pharmaceuticals Limited (524632) RECORD DATE 02.02.2023 PURPOSE Issue of 6 (Six) Equity Shares of Rs.10/- each for cash at a premium of Rs.10/- on rights basis for every 01 (One) Equity Share held.* Ex-Right basis from Date & Sett. No. 02/02/2023 DR-711/2022-2023 * Note : Issue Price of Rs.20/- payabe as - An amount of Rs. 5 per Rights Equity Share to be paid on Application and balance to be paid in three calls as determined by our Board at its sole discretion from time to time. Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 31.01.2023)	02-Feb-2023	6:1
25-Apr-2024	BC	The Company is informing the exchange about allotment of bonus shares The Company has received approval from shareholders to issue bonus shares through postal ballot on April 03rd 2024 and the BSE	25-Apr-2024
06-Apr-2024	BC	The Board of directors has April 20, 2024 as record date.	20-Apr-2024
08-Apr-2024	BC	3:1 Bonus Issues of Equity Shares Trading Members of the Exchange are hereby informed that, SHUKRA PHARMACEUTICALS LIMITED has fixed Record Date for the purpose of Bonus Issue of Equity Shares of	20-Apr-2024
06-Apr-2024	BC	The Board of directors has April 20, 2024 as record date.	06-Apr-2024
29-Feb-2024	BC	Approved postal ballot notice for seeking consent of Members of the Company for the Resolutions as set out in the postal ballot Notice and other matters inci thereto. The Company hereby submits th	03-Apr-2024

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)10

Ratio6:1

Book Closure

Record Date	Split Date	Purpose
25-Apr-2024	-	The Company is informing the exchange about allotment of bonus shares The Company has received approval from shareholders to issue bonus shares through postal ballot on April 03rd 2024 and the BSE
20-Apr-2024	-	The Board of directors has April 20, 2024 as record date.
20-Apr-2024	-	3:1 Bonus Issues of Equity Shares Trading Members of the Exchange are hereby informed that, SHUKRA PHARMACEUTICALS LIMITED has fixed Record Date for the purpose of Bonus Issue of Equity Shares of
06-Apr-2024	-	The Board of directors has April 20, 2024 as record date.
03-Apr-2024	01 Jan'1900	Approved postal ballot notice for seeking consent of Members of the Company for the Resolutions as set out in the postal ballot Notice and other matters inci thereto. The Company hereby submits th

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Shukra Pharmaceuticals Ltd ₹93.40(+1.80/1.97%)	93.40	+1.80	408.98	327.46	22.08	9.24
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	18.89	24.64	20.16	46.25	2.30	3.72
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	18.89	24.64	20.16	46.25	2.30	3.72
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.56	0.24	0.63	0.89	0.27	0.03
Total Income	19.45	24.88	20.79	47.14	2.57	3.75
Total Expenditure	9.35	19.55	19.82	42.59	2.02	3.25
PBIDT	10.11	5.33	0.97	4.54	0.55	0.50
Interest	0.07	0.06	0.08	0.07	0.05	0.04
PBDT	10.04	5.27	0.89	4.47	0.50	0.46
Depreciation	0.51	0.56	0.46	0.51	0.46	0.45
Tax	0.10	0.00	0.00	-0.03	0.00	-0.08
Deferred Tax	0.00	-0.01	0.01	0.02	0.02	0.01
Reported Profit After Tax	9.42	4.71	0.42	3.98	0.03	0.08
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	9.42	4.71	0.42	3.98	0.03	0.08

EPS (Unit Curr.)	8.61	1.47	0.59	10.14	0.16	0.49
EPS (Adj) (Unit Curr.)	2.15	0.37	0.15	2.54	0.01	0.03
Calculated EPS (Unit Curr.)	8.61	4.33	0.59	10.16	0.16	0.49
Calculated EPS (Adj) (Unit Curr.)	2.15	1.08	0.15	2.54	0.01	0.03
Calculated EPS (Ann.) (Unit Curr.)	34.43	17.34	2.35	40.64	0.66	1.95
Calculated EPS (Adj) (Ann.) (Unit Curr.)	8.61	4.34	0.59	10.16	0.03	0.10
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.95	10.86	7.16	3.91	1.57	1.57
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	53.52	21.63	4.81	9.82	23.91	13.44
PBDTM(%)	53.15	21.39	4.41	9.66	21.74	12.37
PATM(%)	49.87	19.12	2.08	8.61	1.30	2.15

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	3.91	1.57	1.57	1.57	1.57	1.57
Reserves Total	21.38	14.78	14.03	13.85	13.81	13.44
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	25.29	16.35	15.60	15.42	15.38	15.01
Secured Loans	2.21	1.10	0.66	0.00	0.00	0.00
Unsecured Loans	2.87	2.28	9.11	8.05	6.06	3.58
Total Debt	5.08	3.38	9.77	8.05	6.06	3.58
Total Liabilities	30.37	19.73	25.37	23.47	21.44	18.59
APPLICATION OF FUNDS :
Gross Block	39.55	35.07	33.53	31.74	28.51	26.06
Less : Accumulated Depreciation	19.32	17.49	15.83	14.36	12.90	11.94
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	20.23	17.58	17.70	17.38	15.61	14.12
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	1.66	1.66	1.66	1.66	1.66	1.66
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.19	0.05	0.05	0.05
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	3.16	3.95	1.68	1.39	0.27	0.14
Sundry Debtors	30.19	7.40	9.75	7.95	5.35	2.93
Cash and Bank	3.97	0.29	0.50	0.13	0.25	0.06
Loans and Advances	15.76	4.23	4.13	4.99	5.21	5.14
Total Current Assets	53.07	15.87	16.06	14.45	11.07	8.27
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	41.19	12.13	6.35	6.46	3.15	1.93
Provisions	0.00	0.00	0.69	0.52	0.85	0.73
Total Current Liabilities	41.19	12.13	7.04	6.98	4.00	2.66
Net Current Assets	11.88	3.75	9.02	7.47	7.08	5.61
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	3.29	3.26	3.20	3.10	2.96	2.85
Net Deferred Tax	-3.29	-3.26	-3.20	-3.10	-2.96	-2.85
Total Assets	30.48	19.73	25.36	23.46	21.44	18.59
Contingent Liabilities	1.40	1.40	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.29	0.50	0.13	0.25	0.06
Net Cash from Operating Activities	3.17	7.99	0.54	1.24	0.26
Net Cash Used In Investing Activities	-4.43	-1.53	-1.89	-3.36	-2.45
Net Cash Used In Financing Activities	4.94	-6.68	1.74	1.99	2.38
Net Inc./Dec In Cash And Cash Equivalents	3.68	-0.21	0.38	-0.12	0.18
Cash And Cash Equivalents At End Of The Year	3.97	0.29	0.50	0.13	0.25

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

50.96%

FII Shareholding

0.00%

DII Shareholding

0.11%

Public Shareholding

48.93%

**Promoter pledged shareholding 50.96%

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 408.98 crores. It has reported a sales of Rs. 18.89 crores and a net profit of Rs. 9.42 crores for the quarter ended December 2018. The company management includes Dakshesh Shah, Dakshesh Shah,Payal Mehta,Bhoomiben Patel,Sarjeevan Singh,Sonal Deepalbhai Gandhi,Sanskruti Patel,Dhruvin Shah,Pinki Nirmal Sagar (Shukra Pharmaceuticals Ltd) among others.

Chairman

Dakshesh Shah

Registered office

3 rd Floor Dev House,Opp WIAA Office Judges Bungalo,Ahmedabad,Gujarat,380054

FAX :

Background

Incorporation Year1993

Face Value₹10

Market Lot1

How to buy Shukra Pharma. shares on nse?

To buy Shukra Pharma. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Shukra Pharma. share price today?

The Shukra Pharma. shares price on nse is Rs.93.4 today.

What is the market cap of Shukra Pharma. shares on BSE ?

The company has a market capitalization of Rs.408.98Cr

What is the PE & PB ratio of Shukra Pharma. shares ?

PE is 22.08 and PB is 9.24

What is the 52 Week High and Low of Shukra Pharma. shares?

Shukra Pharma. stock price high: Rs.97 Shukra Pharma. stock price low: Rs.20.43